The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
- PMID: 15210960
- PMCID: PMC470762
- DOI: 10.1073/pnas.0403495101
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Abstract
In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.
Figures
Similar articles
-
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.J Neural Transm (Vienna). 2006 Jun;113(6):757-67. doi: 10.1007/s00702-006-0453-2. Epub 2006 Apr 28. J Neural Transm (Vienna). 2006. PMID: 16755380
-
Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.Neuroscience. 2005;135(3):829-38. doi: 10.1016/j.neuroscience.2005.06.049. Epub 2005 Sep 13. Neuroscience. 2005. PMID: 16165292
-
Neuromelanin in parkinsonian disorders: an update.Int J Neurosci. 2017 Dec;127(12):1116-1123. doi: 10.1080/00207454.2017.1325883. Epub 2017 May 11. Int J Neurosci. 2017. PMID: 28460588 Review.
-
Copper pathology in vulnerable brain regions in Parkinson's disease.Neurobiol Aging. 2014 Apr;35(4):858-66. doi: 10.1016/j.neurobiolaging.2013.09.034. Epub 2013 Oct 2. Neurobiol Aging. 2014. PMID: 24176624
-
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.Mol Pathol. 2001 Dec;54(6):414-8. Mol Pathol. 2001. PMID: 11724917 Free PMC article. Review.
Cited by
-
Metabolic energy decline coupled dysregulation of catecholamine metabolism in physiologically highly active neurons: implications for selective neuronal death in Parkinson's disease.Front Aging Neurosci. 2024 Feb 21;16:1339295. doi: 10.3389/fnagi.2024.1339295. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38450382 Free PMC article.
-
Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges.Int J Mol Sci. 2024 Feb 7;25(4):2009. doi: 10.3390/ijms25042009. Int J Mol Sci. 2024. PMID: 38396687 Free PMC article. Review.
-
Automatic Geometry-based Estimation of the Locus Coeruleus Region on T1-Weighted Magnetic Resonance Images.bioRxiv [Preprint]. 2024 Jan 24:2024.01.23.576958. doi: 10.1101/2024.01.23.576958. bioRxiv. 2024. PMID: 38328208 Free PMC article. Preprint.
-
Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.J Neural Transm (Vienna). 2024 Mar;131(3):213-228. doi: 10.1007/s00702-023-02718-2. Epub 2024 Jan 18. J Neural Transm (Vienna). 2024. PMID: 38238531
-
Common and Trace Metals in Alzheimer's and Parkinson's Diseases.Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721. Int J Mol Sci. 2023. PMID: 37958705 Free PMC article. Review.
References
-
- Foote, S. L., Freedman, R. & Oliver, A. P. (1975) Brain Res. 86, 229-242. - PubMed
-
- Arnsten, A. F. & Goldman-Rakic, P. S. (1987) J. Neural Transm. 24, 317-324. - PubMed
-
- Mason, S. T. & Fibiger, H. C. (1979) J. Comp. Neurol. 187, 703-724. - PubMed
-
- Nygren, L. G. & Olson, L. (1977) Brain Res. 132, 85-93. - PubMed
-
- German, D. C., Manaye, K. F., White, C. L. III, Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N. & Mann, D. M. (1992) Ann. Neurol. 32, 667-676. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
